The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glucagon Drug Market Research Report 2025
Synopsis
Glucagon?is a?prescription drug?for injection is a?gastrointestinal?motility inhibitor indicated for use as a diagnostic aid during?radiologic?examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
The global Glucagon Drug market was valued at US$ 3652 million in 2023 and is anticipated to reach US$ 5306.7 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Glucagon Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Drug.
Report Scope
The Glucagon Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucagon Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucagon?is a?prescription drug?for injection is a?gastrointestinal?motility inhibitor indicated for use as a diagnostic aid during?radiologic?examinations to temporarily inhibit movement of the gastrointestinal (GI) tract.
The global Glucagon Drug market was valued at US$ 3652 million in 2023 and is anticipated to reach US$ 5306.7 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Glucagon Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Drug.
Report Scope
The Glucagon Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucagon Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glucagon Drug Market Overview
1.1 Product Overview and Scope of Glucagon Drug
1.2 Glucagon Drug Segment by Type
1.2.1 Global Glucagon Drug Market Value Comparison by Type (2024-2030)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Drug Segment by Application
1.3.1 Global Glucagon Drug Market Value by Application: (2024-2030)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Drug Market Size Estimates and Forecasts
1.4.1 Global Glucagon Drug Revenue 2019-2030
1.4.2 Global Glucagon Drug Sales 2019-2030
1.4.3 Global Glucagon Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucagon Drug Market Competition by Manufacturers
2.1 Global Glucagon Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucagon Drug Average Price by Manufacturers (2019-2024)
2.4 Global Glucagon Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucagon Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon Drug, Product Type & Application
2.7 Glucagon Drug Market Competitive Situation and Trends
2.7.1 Glucagon Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucagon Drug Players Market Share by Revenue
2.7.3 Global Glucagon Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Drug Retrospective Market Scenario by Region
3.1 Global Glucagon Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucagon Drug Global Glucagon Drug Sales by Region: 2019-2030
3.2.1 Global Glucagon Drug Sales by Region: 2019-2024
3.2.2 Global Glucagon Drug Sales by Region: 2025-2030
3.3 Global Glucagon Drug Global Glucagon Drug Revenue by Region: 2019-2030
3.3.1 Global Glucagon Drug Revenue by Region: 2019-2024
3.3.2 Global Glucagon Drug Revenue by Region: 2025-2030
3.4 North America Glucagon Drug Market Facts & Figures by Country
3.4.1 North America Glucagon Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucagon Drug Sales by Country (2019-2030)
3.4.3 North America Glucagon Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucagon Drug Market Facts & Figures by Country
3.5.1 Europe Glucagon Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucagon Drug Sales by Country (2019-2030)
3.5.3 Europe Glucagon Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Glucagon Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucagon Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Glucagon Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glucagon Drug Market Facts & Figures by Country
3.7.1 Latin America Glucagon Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucagon Drug Sales by Country (2019-2030)
3.7.3 Latin America Glucagon Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucagon Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucagon Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Drug Sales by Type (2019-2030)
4.1.1 Global Glucagon Drug Sales by Type (2019-2024)
4.1.2 Global Glucagon Drug Sales by Type (2025-2030)
4.1.3 Global Glucagon Drug Sales Market Share by Type (2019-2030)
4.2 Global Glucagon Drug Revenue by Type (2019-2030)
4.2.1 Global Glucagon Drug Revenue by Type (2019-2024)
4.2.2 Global Glucagon Drug Revenue by Type (2025-2030)
4.2.3 Global Glucagon Drug Revenue Market Share by Type (2019-2030)
4.3 Global Glucagon Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucagon Drug Sales by Application (2019-2030)
5.1.1 Global Glucagon Drug Sales by Application (2019-2024)
5.1.2 Global Glucagon Drug Sales by Application (2025-2030)
5.1.3 Global Glucagon Drug Sales Market Share by Application (2019-2030)
5.2 Global Glucagon Drug Revenue by Application (2019-2030)
5.2.1 Global Glucagon Drug Revenue by Application (2019-2024)
5.2.2 Global Glucagon Drug Revenue by Application (2025-2030)
5.2.3 Global Glucagon Drug Revenue Market Share by Application (2019-2030)
5.3 Global Glucagon Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Glucagon Drug Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Glucagon Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Glucagon Drug Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Corporation Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Torrent Labs Glucagon Drug Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Drug Industry Chain Analysis
7.2 Glucagon Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Drug Production Mode & Process
7.4 Glucagon Drug Sales and Marketing
7.4.1 Glucagon Drug Sales Channels
7.4.2 Glucagon Drug Distributors
7.5 Glucagon Drug Customers
8 Glucagon Drug Market Dynamics
8.1 Glucagon Drug Industry Trends
8.2 Glucagon Drug Market Drivers
8.3 Glucagon Drug Market Challenges
8.4 Glucagon Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
